85 related articles for article (PubMed ID: 22153558)
1. A long duration of the prediagnostic symptomatic interval is not associated with an unfavourable prognosis in childhood medulloblastoma.
Gerber NU; von Hoff K; von Bueren AO; Treulieb W; Deinlein F; Benesch M; Zwiener I; Soerensen N; Warmuth-Metz M; Pietsch T; Mittler U; Kuehl J; Kortmann RD; Grotzer MA; Rutkowski S
Eur J Cancer; 2012 Sep; 48(13):2028-36. PubMed ID: 22153558
[TBL] [Abstract][Full Text] [Related]
2. Prognostic relevance of clinical and biological risk factors in childhood medulloblastoma: results of patients treated in the prospective multicenter trial HIT'91.
Rutkowski S; von Bueren A; von Hoff K; Hartmann W; Shalaby T; Deinlein F; Warmuth-Metz M; Soerensen N; Emser A; Bode U; Mittler U; Urban C; Benesch M; Kortmann RD; Schlegel PG; Kuehl J; Pietsch T; Grotzer M
Clin Cancer Res; 2007 May; 13(9):2651-7. PubMed ID: 17473196
[TBL] [Abstract][Full Text] [Related]
3. Which clinical and biological tumor markers proved predictive in the prospective multicenter trial HIT'91--implications for investigating childhood medulloblastoma.
Grotzer MA; von Hoff K; von Bueren AO; Shalaby T; Hartmann W; Warmuth-Metz M; Emser A; Kortmann RD; Kuehl J; Pietsch T; Rutkowski S
Klin Padiatr; 2007; 219(6):312-7. PubMed ID: 18050040
[TBL] [Abstract][Full Text] [Related]
4. Is there a correlation between duration of presenting symptoms and stage of medulloblastoma at the time of diagnosis?
Halperin EC; Friedman HS
Cancer; 1996 Aug; 78(4):874-80. PubMed ID: 8756384
[TBL] [Abstract][Full Text] [Related]
5. Infants with medulloblastoma: a single institution review of survival.
Geyer R; Levy M; Berger MS; Milstein J; Griffin B; Bleyer WA
Neurosurgery; 1991 Nov; 29(5):707-10; discussion 710-1. PubMed ID: 1961400
[TBL] [Abstract][Full Text] [Related]
6. Large cell/anaplastic medulloblastoma: outcome according to myc status, histopathological, and clinical risk factors.
von Hoff K; Hartmann W; von Bueren AO; Gerber NU; Grotzer MA; Pietsch T; Rutkowski S
Pediatr Blood Cancer; 2010 Mar; 54(3):369-76. PubMed ID: 19908297
[TBL] [Abstract][Full Text] [Related]
7. Radiation treatment for medulloblastoma: a review of 64 cases at a single institute.
Liu Y; Zhu Y; Gao L; Xu G; Yi J; Liu X; Li Y
Jpn J Clin Oncol; 2005 Mar; 35(3):111-5. PubMed ID: 15741299
[TBL] [Abstract][Full Text] [Related]
8. Histopathological prognostic factors in medulloblastoma: high expression of survivin is related to unfavourable outcome.
Haberler C; Slavc I; Czech T; Gelpi E; Heinzl H; Budka H; Urban C; Scarpatetti M; Ebetsberger-Dachs G; Schindler C; Jones N; Klein-Franke A; Maier H; Jauk B; Kiefer A; Hainfellner JA
Eur J Cancer; 2006 Nov; 42(17):2996-3003. PubMed ID: 16996732
[TBL] [Abstract][Full Text] [Related]
9. Impact of site of tumor recurrence upon survival for children with recurrent or progressive medulloblastoma.
Bowers DC; Gargan L; Weprin BE; Mulne AF; Elterman RD; Munoz L; Giller CA; Winick NJ
J Neurosurg; 2007 Jul; 107(1 Suppl):5-10. PubMed ID: 17644914
[TBL] [Abstract][Full Text] [Related]
10. Adult medulloblastoma: an analysis of survival and prognostic factors.
Le QT; Weil MD; Wara WM; Lamborn KR; Prados MD; Edwards MS; Gutin PH
Cancer J Sci Am; 1997; 3(4):238-45. PubMed ID: 9263630
[TBL] [Abstract][Full Text] [Related]
11. Surveillance scanning of children with medulloblastoma.
Torres CF; Rebsamen S; Silber JH; Sutton LN; Bilaniuk LT; Zimmerman RA; Goldwein JW; Phillips PC; Lange BJ
N Engl J Med; 1994 Mar; 330(13):892-5. PubMed ID: 8114859
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors after extraneural metastasis of medulloblastoma.
Mazloom A; Zangeneh AH; Paulino AC
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):72-8. PubMed ID: 20133080
[TBL] [Abstract][Full Text] [Related]
13. Childhood medulloblastoma in Ontario, 1977-1987: population-based results.
Danjoux CE; Jenkin RD; McLaughlin J; Grimard L; Gaspar LE; Dar AR; Fisher B; Whitton AC; Kraus V; Springer CD
Med Pediatr Oncol; 1996 Jan; 26(1):1-9. PubMed ID: 7494506
[TBL] [Abstract][Full Text] [Related]
14. Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol.
von Bueren AO; Friedrich C; von Hoff K; Kwiecien R; Müller K; Pietsch T; Warmuth-Metz M; Hau P; Benesch M; Kuehl J; Kortmann RD; Rutkowski S
Eur J Cancer; 2015 Nov; 51(16):2434-43. PubMed ID: 26254812
[TBL] [Abstract][Full Text] [Related]
15. Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapy.
Rutkowski S; Gerber NU; von Hoff K; Gnekow A; Bode U; Graf N; Berthold F; Henze G; Wolff JE; Warmuth-Metz M; Soerensen N; Emser A; Ottensmeier H; Deinlein F; Schlegel PG; Kortmann RD; Pietsch T; Kuehl J;
Neuro Oncol; 2009 Apr; 11(2):201-10. PubMed ID: 18818397
[TBL] [Abstract][Full Text] [Related]
16. Duration of symptoms prior to diagnosis is related inversely to presenting disease stage in children with medulloblastoma.
Halperin EC; Watson DM; George SL
Cancer; 2001 Apr; 91(8):1444-50. PubMed ID: 11301391
[TBL] [Abstract][Full Text] [Related]
17. [Clinical course and prognosis in medulloblastoma in infants and young children].
Wagner W; Böttcher HD; Korinthenberg R; Schadel A; Schmilowski M
Klin Padiatr; 1983 Mar; 195(2):100-2. PubMed ID: 6855144
[TBL] [Abstract][Full Text] [Related]
18. [Medulloblastoma in children. A 20-year case load].
Hovind KH; Lie SO
Tidsskr Nor Laegeforen; 1989 Nov; 109(33):3412-5. PubMed ID: 2609301
[TBL] [Abstract][Full Text] [Related]
19. A clinicobiological model predicting survival in medulloblastoma.
Ray A; Ho M; Ma J; Parkes RK; Mainprize TG; Ueda S; McLaughlin J; Bouffet E; Rutka JT; Hawkins CE
Clin Cancer Res; 2004 Nov; 10(22):7613-20. PubMed ID: 15569993
[TBL] [Abstract][Full Text] [Related]
20. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
